NPI: 1184004137 · SOUTH GATE, CA 90280 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/04/2015
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 06/04/2015 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,860 | $1.24M |
| 2019 | 8,601 | $664K |
| 2020 | 15,017 | $1.42M |
| 2021 | 25,367 | $1.78M |
| 2022 | 17,781 | $1.63M |
| 2023 | 19,652 | $2.03M |
| 2024 | 16,090 | $1.46M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 53,769 | 5,126 | $7.02M |
| 0821 | 2,919 | 718 | $2.53M | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 17,292 | 2,386 | $455K |
| 90945 | 1,945 | 75 | $79K | |
| J1756 | Injection, iron sucrose, 1 mg | 7,531 | 2,712 | $72K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,279 | 829 | $23K |
| J1270 | Injection, doxercalciferol, 1 mcg | 7,845 | 1,168 | $16K |
| A4657 | Syringe, with or without needle, each | 7,012 | 2,384 | $16K |
| 0250 | 3,714 | 252 | $6K | |
| 90674 | 173 | 169 | $2K | |
| 83970 | 1,568 | 1,509 | $1K | |
| 90747 | 26 | 25 | $1K | |
| 83540 | 1,327 | 1,264 | $823.62 | |
| 0302 | 89 | 82 | $820.53 | |
| 85048 | 1,625 | 1,558 | $700.20 | |
| 82728 | 1,233 | 1,186 | $612.75 | |
| 90662 | 100 | 95 | $566.46 | |
| 82108 | 222 | 208 | $513.64 | |
| 83550 | 951 | 900 | $391.96 | |
| 85041 | 1,614 | 1,548 | $207.87 | |
| G0008 | Administration of influenza virus vaccine | 91 | 84 | $104.66 |
| 90661 | 13 | 13 | $43.56 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 30 | 27 | $3.44 |